Journals / Bağcılar Tıp Bülteni / 2021 / Cilt: 6 - Sayı: 4

Does Vitamin D Level Affect Beta Cell Activity?

D Vitamini Seviyesi Beta Hücre Aktivitesini Etkiler mi?

Pages
397–406
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Results: It was found that 89.9% of the patients with type 2 diabetes, 90.6% of the insulin resistance patients, 91.7% of the obesity patients and 94.1% of the impaired fast glucose patients had less than 30 ng/ mL of serum 25(OH)D concentration.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The prevalence of vitamin D deficiency is ever-increasing throughout the world.
📊
Key Findings & Data:This research study was carried out to assess serum vitamin D levels of patients with type 2 diabetes, insulin resistance, obesity, and impaired fasting glucose.
💡
Conclusion & Impact:Results: It was found that 89.9% of the patients with type 2 diabetes, 90.6% of the insulin resistance patients, 91.7% of the obesity patients and 94.1% of the impaired fast glucose patients had less than 30 ng/ mL of serum 25(OH)D concentration.
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: The prevalence of vitamin D deficiency is ever-increasing throughout the world. Vitamin D deficiency is associated with disorders such as diabetes, insulin resistance, obesity, dyslipidemia, and hypertension. This research study was carried out to assess serum vitamin D levels of patients with type 2 diabetes, insulin resistance, obesity, and impaired fasting glucose. Method: This study was carried out on 504 patients, who were newly diagnosed and did not receive medication before, aged 18 to 80 years, and who had type 2 diabetes, insulin resistance, obesity, and impaired fasting glucose. Their fasting glucose, fasting insulin, total cholesterol, high-density lipoprotein (HDL)-cholesterol, low-density lipoproteincholesterol, triglyceride, 25(OH)D concentration, height and body weight measurements were analyzed retrospectively. Body mass index, homeostatic model assessment (HOMA) for insulin resistance and HOMA beta (B) values of the patients were calculated. Results: It was found that 89.9% of the patients with type 2 diabetes, 90.6% of the insulin resistance patients, 91.7% of the obesity patients and 94.1% of the impaired fast glucose patients had less than 30 ng/ mL of serum 25(OH)D concentration. It was seen that the serum 25(OH) D concentrations of the patients were negatively correlated with their fasting insulin concentrations and HOMA B values, and positively correlated with their HDL-cholesterol levels. Conclusion: Based on this study, vitamin D deficiency was found to be common in the patients with type 2 diabetes, insulin resistance, obesity, and impaired fasting glucose. Serum 25(OH)D concentrations were correlated with the levels of fasting insulin, HDL-cholesterol, and betacell function. Keywords: HOMA B, HOMA-IR, insulin resistance, obesity, type 2 diabetes, vitamin D

Özet

Amaç: D vitamini yetersizliği tüm dünyada giderek artmaktadır. D vitamini yetersizliği diyabet, insülin direnci, obezite, dislipidemi ve hipertansiyon gibi düzensizlikler ile ilişkilidir. Bu araştırma tip 2 diyabet, insülin direnci, obezite ve bozulmuş açlık glikozu olan hastaların serum D vitamini düzeylerini değerlendirmek amacıyla yapılmıştır. Yöntem: Bu araştırma, 18-80 yaş arası yeni tanı konulmuş ve daha önce ilaç tedavisi almamış, tip 2 diyabet, insülin direnci, obezite ve bozulmuş açlık glikozu olan 504 bireyin bulguları incelenerek yapılmıştır. Hastaların açlık glikoz, açlık insülin, total kolesterol, yüksek yoğunluklu lipoprotein (HDL)-kolesterol, düşük yoğunluklu lipoprotein-kolesterol, trigliserit, 25(OH)D konsantrasyonları, boy ve vücut ağırlığı ölçümleri retrospektif olarak analiz edilmiştir. Hastaların vücut kütle indeksi, insülin direncinin homeostatik modeli değerlendirmesi (HOMA) ve HOMA beta (B) değerleri hesaplanmıştır. Bulgular: Tip 2 diyabetli hastaların %89,9’unun, insülin direnci hastalarının %90,6’sının, obezite hastalarının %91,7’sinin ve bozulmuş açlık glikozu hastalarının %94,1’inin serum 25(OH)D konsantrasyonlarının 30 mg/mL’nin altında olduğu bulunmuştur. Serum 25(OH)D konsantrasyonu ile açlık insülin konsantrasyonu ve HOMA B değerleri arasında negatif korelasyon, HDL-kolesterol seviyesi ile pozitif korelasyon olduğu görülmüştür. Sonuç: Bu çalışmada tip 2 diyabet, insülin direnci, obezite ve bozulmuş glikoz toleransı hastalarında D vitamini yetersizliği sık görülmüştür. Serum 25(OH)D konsantrasyonu açlık insülin, HDL-kolesterol ve beta hücre fonksiyonu ile ilişkili bulunmuştur. Anahtar kelimeler: HOMA B, HOMA-IR, insülin direnci, obezite, tip 2 diyabet, vitamin D

🔖

Cite This Article

ÖZKAN, G. Ö. (2022). Does Vitamin D Level Affect Beta Cell Activity?. Bağcılar Tıp Bülteni, Cilt: 6 - Sayı: 4, 397–406. https://ajindex.com/articles/458955

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Cordeiro A, Santos A, Bernardes M, Ramalho A, Martins MJ. Vitamin D metabolism in human adipose tissue: Could it explain low vitamin D status in obesity? Horm Mol Biol Clin Investig 2017;33:/j/ hmbci.2018.33.issue-2/hmbci-2017-0003/hmbci-2017-0003.xml. doi: 10.1515/hmbci-2017-0003
  2. Mousa A, Naderpoor N, de Courten MPJ, Scragg R, de Courten B. 25-hydroxyvitamin D is associated with adiposity and cardiometabolic risk factors in a predominantly vitamin D-deficient and overweight/obese but otherwise healthy cohort. J Steroid Biochem Mol Biol 2017;173:258-264
  3. Prasad P, Kochhar A. Interplay of vitamin D and metabolic syndrome: a review. Diabetes Metab Syndr Clin Res Rev 2016;10(2):105-112
  4. Matyjaszek-Matuszek B, Lenart-Lipi ska M, Wo niakowska E. Clinical implications of vitamin D deficiency. Prz Menopauzalny 2015;14(2):75-81
  5. Sun X, Cao ZB, Tanisawa K, Ito T, Oshima S, Higuchi M. Vitamin D supplementation reduces insulin resistance in Japanese adults: a secondary analysis of a double-blind, randomized, placebocontrolled trial. Nutr Res 2016;36(10):1121-1129
  6. Gao Y, Zheng T, Ran X, Ren Y, Chen T, Zhong L, et al. Vitamin D and incidence of prediabetes or type 2 diabetes: A four-year followup community-based study. Dis Markers 2018;2018:1926308. doi: 10.1155/2018/1926308 7. Wallace IR, McKinley MC, McEvoy CT, Hamill LL, Ennis CN, McGinty A, et al. Serum 25-hydroxyvitamin D and insulin resistance in people at high risk of cardiovascular disease: a euglycaemic hyperinsulinaemic clamp study. Clin Endocrinol (Oxf) 2016;85(3):386-392
  7. Poolsup N, Suksomboon N, Plordplong N. Effect of vitamin D supplementation on insulin resistance and glycaemic control in prediabetes: a systematic review and meta-analysis. Diabet Med 2016;33(3):290-299
  8. Kartika R, Wibowo H. Vitamin D suppresses inflammatory responses in insulin resistance. J thee Med Sci (Berkala Ilmu Kedokteran) 2020;52(02):171-180
  9. Corica D, Zusi C, Olivieri F, Marigliano M, Piona C, Fornari E, et al. Vitamin D affects insulin sensitivity and β-cell function in obese non-diabetic youths. Eur J Endocrinol 2019;181(4):439-450
  10. Kelishadi R, Salek S, Salek M, Hashemipour M, Movahedian M. Effects of vitamin D supplementation on insulin resistance and cardiometabolic risk factors in children with metabolic syndrome: a triple-masked controlled trial. J Pediatr (Rio J) 2014;90(1):28-34
  11. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care 2004;27(6):1487-1495. 13